Market revenue in 2022 | USD 57.9 million |
Market revenue in 2030 | USD 93.0 million |
Growth rate | 6.1% (CAGR from 2022 to 2030) |
Largest segment | Probiotics |
Fastest growing segment | Probiotics |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Probiotics, Prebiotics, Organic Acids, Phtyogenics |
Key market players worldwide | DSM Firmenich AG, Mitsui & Co Ltd, Lallemand, Beneo, Kemin Industries, DuPont de Nemours Inc, Novonesis AS ADR, Associated British Foods PLC, Novozymes, Evonik Industries AG, Basf SE, Cargill, Archer-Daniels Midland Co, China National Bluestar Group |
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eubiotics market will help companies and investors design strategic landscapes.
Probiotics was the largest segment with a revenue share of 36.79% in 2022. Horizon Databook has segmented the Middle East & Africa eubiotics market based on probiotics, prebiotics, organic acids, phtyogenics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa eubiotics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa eubiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account